Study Physician
Swedish Orphan Biovitrum · Swedish Orphan Biovitrum AB (publ) · Astellas Pharma Global Development, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
36
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
3
PubMed author-name match
Trials
Studies that name Study Physician as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:50 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07909005 · Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant.Swedish Orphan Biovitrum · not yet recruiting · Hemophagocytic Lymphohistiocytosis (HLH), Macrophage Activation Syndrome (MAS), Still Disease · study director
- Ph3NCT07898774 · A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsSwedish Orphan Biovitrum · recruiting · C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent Glomerular Disease After Kidney Transplantation · study director
- Ph1/Ph2NCT07770685 · A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve DamageAstellas Pharma Global Development, Inc. · recruiting · Glaucoma · study director
- Ph1/Ph2NCT07488676 · A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsAstellas Pharma Global Development, Inc. · recruiting · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma · study director
- N/ANCT06992505 · Assessment of Macrophage Activation syndromE in STill's Disease in ItalySwedish Orphan Biovitrum · completed · Macrophage Activation Syndrome (MAS), Still Disease, Juvenile Onset, Still's Disease, Adult-Onset · study director
- Ph4NCT06940830 · Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog AlfaSwedish Orphan Biovitrum · active not recruiting · Hemophilia A · study director
- Ph2NCT06812754 · A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through MenopauseAstellas Pharma Global Development, Inc. · completed · Hot Flashes · study director
- Ph2NCT06782373 · A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Swedish Orphan Biovitrum · recruiting · VEXAS, VEXAS Syndrome · study director
- Ph4NCT06752850 · A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa ProphylaxisSwedish Orphan Biovitrum · active not recruiting · Haemophilia A (Moderate or Severe), Hemophilia, Classic, Haemophilia · study director
- Ph3NCT05817812 · A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog AlfaSwedish Orphan Biovitrum · completed · Hemophilia A, Severe · study director
- Ph1/Ph2NCT05309668 · Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNAstraZeneca · active not recruiting · Neurofibromatosis Type 1 · study director
- Ph2NCT05148299 · A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantationSwedish Orphan Biovitrum · completed · Transplant-Associated Thrombotic Microangiopathy · study director
- Ph1NCT05101148 · Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform NeurofibromasAstraZeneca · active not recruiting · Neurofibromatosis Type 1 · study director
- Ph3NCT05096403 · A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)Swedish Orphan Biovitrum · completed · Cold Agglutinin Disease · study director
- N/ANCT04731701 · Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)Swedish Orphan Biovitrum · completed · Hemophilia A, Hemophilia B · study director
- N/ANCT04293523 · A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint HealthSwedish Orphan Biovitrum · completed · Hemophilia A · study director
- N/ANCT04262284 · Respreeza® Self-administration and Learning Program (AmAREtTI Study)CSL Behring · completed · Alpha-1 Antitrypsin Deficiency · study director
- Ph1NCT04257617 · A Trial of ZL-1201 in Subjects With Advanced CancerZai Lab (Shanghai) Co., Ltd. · completed · Advanced Cancer · study director
- N/ANCT03932344 · Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)Swedish Orphan Biovitrum · completed · Still Disease, Juvenile Onset · study director
- Ph2/Ph3NCT03805789 · The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell TransplantCSL Behring · terminated · Acute-graft-versus-host Disease · study director
- N/ANCT03582449 · Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)Shire · completed · Hunter Syndrome · study director
- Ph3NCT03336645 · Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in JapanShire · completed · Nervous System Diseases · study director
- N/ANCT03291223 · Gaucher Disease Outcome Survey (GOS)Shire · recruiting · Gaucher Disease · study director
- Ph4NCT03103542 · Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI TherapiesSwedish Orphan Biovitrum · completed · Hemophilia A · study director
- N/ANCT03055611 · A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or BSwedish Orphan Biovitrum · completed · Haemophilia A, Haemophilia B · study director
- Ph4NCT03033745 · Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)CSL Behring · completed · Primary Immunodeficiency · study director
- N/ANCT02976753 · Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor ProductsSwedish Orphan Biovitrum · completed · Hemophilia A · study director
- Ph3NCT02949362 · Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyShire · completed · Short Bowel Syndrome · principal investigator
- Ph2/Ph3NCT02484638 · Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With InhibitorsCSL Behring · terminated · Hemophilia A With Inhibitors, Hemophilia B With Inhibitors · study director
- N/ANCT02320084 · Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical CareSwedish Orphan Biovitrum · completed · Hereditary Tyrosinemia, Type I · study director
- Ph3NCT02278341 · Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable DialysisAstellas Pharma Europe B.V. · completed · Anemia, End Stage Renal Disease (ESRD) · study director
- Ph1NCT02252731 · A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy SubjectsAstellas Pharma Europe B.V. · completed · Pharmacokinetics of FG-4592, Healthy Subjects · study director
- Ph2NCT01959165 · MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis PatientsAstraZeneca · completed · Ulcerative Colitis · study director
- Ph2NCT01340027 · A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive BladderAstellas Pharma Europe B.V. · completed · Urologic Diseases, Urinary Bladder Diseases, Urological Manifestations · study director
- Early Ph1NCT00689416 · Effects of Crestor on Inflammation of Atherosclerotic PlaquesAstraZeneca · completed · Atherosclerosis, Inflammatory Activity in Carotid Arteries · study chair
- Ph3NCT00577655 · Albuterol HFA MDI in Pediatric Participants With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:50 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study.Urol Oncol · 201411 citationsRCR 0.4
- 4 citationsRCR 0.7
- Effectiveness of Full Spectrum Cannabis Extracts in the Treatment of Chronic Pain: An Open Label Study.J Pain Palliat Care Pharmacother · 20252 citationsRCR 0.9